Vigna Law Group: Investigating the Risks of Sepsis Associated Intravenous Remodulin
“There doesn’t appear to be any long-term benefit of providing Remodulin IV when compared to Sub-Cutaneous injection. The risk of blood infections from intravenous administration of Remodulin using venous access devices such as PICC lines and Ports appear to be unreasonable given there is no long-term benefit other than local pain at the incision site," [...]